myomo.com (MYO) Company Cash Funds

Graphic logo of Myomo, Inc. (MYO)

Cash and cash equivalents demonstrate liquidity dynamics, where 0.01 reflects the baseline level of the metric. Myomo, Inc. (MYO) generates revenue through the sale of innovative MyoPro exoskeletons. Paul Goodinis's effective management is expanding insurance coverage for the products. The uniqueness of the technologies provides significant pricing power, while government payment support stimulates growth in business margins.

Myomo Inc. - MYO Company Cash Balance (period 07/04/2022 - 11/21/2026)

MYO (Myomo, Inc): analytical breakdowns and indicator data

- stock quotes and analyst forecast:
- market capitalization details:
Comprehensive company analysis:myomo.com
Signature product of Myomo Inc.

Liquid asset volume serves as an indicator of internal financial stability, allowing for an assessment of management's ability to sustain operations without resorting to expensive debt capital. For Myomo, Inc. (MYO), the cash trajectory demonstrates the scaling efficiency of the insurance reimbursement system in the US, where resource accumulation coupled with narrow product specialization signals a transition toward a stable recurring revenue model and a reduction in investment risks.

Main competitors

Company Cash Volume BSX|Company Cash Funds EW (Edwards Lifesciences Corporation)|Company Cash Funds ResMed RMD|Company Cash Volume Insulet Corp PODD|ZBH: Company Cash on Hand|Company Cash Balance COO (CooperVision)|ALGN (Align Technology, Inc.) - Company Cash on Hand|Globus Medical, Inc. - Company Cash Balance|TMDX (TransMedics Group Inc) - Company Cash Volume|Company Cash Reserve Alphatec Holdings ATEC|Company Cash Funds CryoLife (AORT)|Enovis Corporation (ENOV) - Company Cash Position|Integra LifeSciences Inc. - Company Cash on Hand|Company Cash Volume Establishment Labs ESTA|Beta Bionics, Inc. - Company Cash Volume|Company Liquid Assets IRADIMED Corp IRMD|Embecta (EMBC) - Company Cash Funds|Company Total Cash Volume TNDM (Tandem Corp)|Company Cash Funds axogeninc.com|Company Cash on Hand SI-BONE, Inc. (SIBN)|Company Cash Volume OFIX|Bioventus Corp - Company Cash and Cash Equivalents|Company Cash Funds orthopediatrics.com KIDS|TMCI: Company Cash and Cash Equivalents|SRTA: Company Cash on Hand|Carlsmed Inc - Company Total Cash Amount|RxSight (RXST) - Company Cash Funds|Company Cash on Hand ClearPoint|Company Cash on Hand STXS|Company Cash Reserve Neuronetics, Inc. STIM|Company Cash Volume SGHT|Company Cash on Hand Orchestra BioMed OBIO|Company Cash Funds Anika Therapeutics Inc. ANIK|NSPR (InspireMD) - Company Total Cash Volume|ZJYL - Company Cash Funds|VANI (vivani.com) - Company Cash and Cash Equivalents|XTNT (Xtant Medical Inc) - Company Cash on Hand|Company Cash Reserve n1mtc.com (NMTC)|Company Cash Funds modular-medical.com|Company Cash on Hand Envoy Medical (COCH)|Company Cash Volume VVOS|NVNO (enVVeno Corp) - Company Cash Balance|Company Cash Volume SINT (Sintx Technologies)|TNON: Company Cash and Cash Equivalents|Lifeward - Company Cash Volume|Company Cash Balance AMIX (Autonomix Medical)|IVF: Company Cash Volume|Company Cash Position Bone Biologics Corporation BBLG|Company Cash on Hand AXNX|BIOLASE, Inc. (BIOL) - Company Liquid Assets|Company Cash Volume DYNT|Company Liquid Assets Paragon 28|Company Cash Volume INVO (INVO Bioscience, Inc.)